News

The FDA plans to “rapidly make available” rare disease drugs and make use of surrogate endpoints to get promising medicines ...
WASHINGTON, D.C. — In a move that has already rattled Wall Street and divided the medical community, the U.S. Food and Drug Administration has appointed Dr. Vinay Prasad—an oncologist ...
A new, highly transmissible COVID subvariant has been detected in California — heightening the risk of a summer wave as ...
Seven weeks into his job as FDA commissioner, Marty Makary, MD, MPH, held his own answering a barrage of sometimes acrimonious questions from Senators about agency staffing cuts, limits on COVID ...
"With the COVID pandemic behind us, it is time to adopt a common-sense approach to COVID policy," a spokesperson for the FDA tells Rolling Stone. "Healthy individuals aged six mon ...
The US Food and Drug Administration (FDA) has announced a significant revision to its COVID-19 vaccination policy, restricting access to seasonal booster shots for healthy Americans under the age of ...
We want to know more about what these products are doing,” said Dr. Vinay Prasad during a recent FDA livestreamed ...
In a significant shift of federal vaccine policy, the Food and Drug Administration announced Tuesday that access to updated COVID-19 vaccines this fall will be limited to older adults and individuals ...
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The FDA will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
WASHINGTON (AP) — Robert F. Kennedy Jr. clinched the political support needed to become the nation’s top health official by pledging to work within the decades-old federal system for approval and use ...
NEW ORLEANS — Last year, hundreds of people poured in to hear Peter Marks, the Food and Drug ... the gene therapy field is what stance Vinay Prasad, the fiery hematologist and frequent pharma ...